Gynecomastia: Causes, Symptoms, and Treatment

How to Get Rid of “Man Boobs” by BodyLogicMD If you’ve ever been too embarrassed to take off your shirt at the beach, you’re probably familiar with the term “man boobs.” At least thirty percent of males are affected by gynecomastia—the medical term for male breasts—in their lifetimes. In fact, it’s the most common condition … Continued

Weight Loss Due to Exercise May Decrease Breast Cancer Risk

Trim Your Breast Cancer Risk by Losing Weight by BodyLogicMD Breast cancer is a topic that personally impacts many people, from those directly battling the disease to friends and family members. As the second most common type of cancer in women, with one in eight women at risk during their lifetimes, the importance of recognizing … Continued

Estrogen metabolites

I have taken care of breast cancer patients as a surgeon for over 25 years. It is a devastating diagnosis because of the severity of the treatments and because it affects so many young women. As I treat women with hormonal imbalance now, I have a different understanding of the importance of using bioidentical hormones … Continued

5 things you can do right now to avoid breast cancer

I was at a conference last weekend where prevention of breast cancer was discussed at length. Although breast cancer awareness month is over, we need to prevent breast cancer all year long. Here are some tips.   1. Stop eating sugar and simple carbs- sugar feeds cancer. Simple carbs are “white” foods like bread, pasta, … Continued

Breast Cancer Risks

Why are so many women getting breast cancer? Another young patient in the office today with a new diagnosis of breast cancer discovered with mammography. It is an early one, and after treatment she will be fine, but it is so disruptive to a person’s psyche and sense of well being. Her body has let … Continued

Breast Cancer

I just saw a patient in my surgical practice with her second primary breast cancer. I took care of her with her first one 11 years ago, and this time she needed a mastectomy. She had been on premarin for about 20 years before her first diagnosis. She is likely to do well but what … Continued

Medical Mondays: How can I reduce my risk of breast cancer?

Medical Mondays – You ask the questions and our highly trained bioidentical hormones experts will post your answer LIVE! Q: After losing a very close friend of mine to breast cancer in 2004, I have been skeptical to try hormone replacement therapy. Last December, while waiting for a delayed flight at the airport, i struck … Continued

Estrogen and Progestin Can Increase Cancer Risk

The Huffington Post recently released a list of possible, probable and known carcinogens that many of us come into contact with on a daily basis. And it’s no surprise that synthetic hormones, such as estrogen and progestin made the cut.

Hormone Therapy May Reduce Likelihood of Breast Cancer in Some Women

Once again physicians are looking at the WHI results and trying to justify the use of Premarin. One has to wonder, given all we know about how toxic this drug is, why do they continue to do so? I wonder if there is a financial incentive from the drug company that manufactures Premarin. I would be curious about who is funding their research. The WHI study used Premarin, a form of estrogen hormone replacement therapy (EHRT) derived from the urine of pregant mares. It is well known to increase the risk of breast cancer, blood clots, and do little to prevent age-related, degenerative diseases, such as dementia or osteoporosis.

Dr. Melinda Silva Discusses Hormone Therapy and Breast Cancer Risk

In a new analysis of the women involved in the Women’s Health Initiative (WHI), researchers discovered that synthetic hormone replacement therapy used after menopause not only increased the risk of breast cancer in women, but also increased their risk of dying from the disease, when compared with women who did not receive treatment. These new findings were recently published in the October 20th issue of the Journal of the American Medical Association. The WHI was a federally funded study that analyzed more than16,500 postmenopausal women who were given either hormone replacement therapy or a placebo.